CardioLogs ECG Analysis Platform vs cmAngio®
AI Verdict
Choose CardioLogs ECG Analysis Platform if…
Choose CardioLogs ECG Analysis Platform if your primary need is rapid and accurate AI-powered analysis of ECG data from a variety of cardiac monitoring devices, including Holters, smartwatches, and ECG patches. This platform is ideal for cardiologists and emergency medicine physicians requiring efficient arrhythmia detection and diagnosis across diverse patient monitoring scenarios.
View CardioLogs ECG Analysis Platform →Choose cmAngio® if…
Choose cmAngio® if you aim to leverage existing mammography screenings to gain insights into a woman's cardiovascular health by detecting Breast Arterial Calcifications (BAC). This tool is best suited for radiologists and OB/GYN specialists looking to incorporate cardiovascular risk assessment into routine breast imaging without additional radiation or procedures.
View cmAngio® →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CardioLogs ECG Analysis Platform | cmAngio® |
|---|---|---|
| Pricing | Unknown | Paid, out-of-pocket |
| Deployment | Cloud-based | Cloud-based, integrates with any DICOM-compliant viewer |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardioLogs ECG Analysis PlatformCardioLogs offers a cloud-based, vendor-neutral platform with multi-device compatibility, including smartwatches, allowing for flexible access and multi-user collaboration. Its user-friendly interface and reported ease of use for less experienced cardiologists after minimal training suggest a highly adaptable and accessible solution.
Clinical Value
CardioLogs ECG Analysis PlatformBoth tools are FDA-cleared and demonstrate strong clinical value. However, CardioLogs has extensive clinical validation showing significant reductions in false positives for AFib (almost 70%) and Holter analysis time (42%), alongside improved VT detection sensitivity. These metrics directly quantify improvements in diagnostic efficiency and accuracy for critical cardiac conditions.
Pricing & Value
CardioLogs ECG Analysis PlatformCardioLogs offers a transparent pricing model based on a 'pay per ECG' structure, providing clarity on cost allocation. While cmAngio mentions potential 'no-cost implementation,' its overall pricing details are not publicly available, making a direct value comparison difficult and giving CardioLogs an edge in pricing transparency.
Enterprise Readiness
CardioLogs ECG Analysis PlatformBoth are cloud-based, HIPAA-compliant, and FDA-cleared. CardioLogs, as a Philips solution, explicitly highlights ISO/IEC 27001 certified AWS servers and robust EHR integration, indicating a mature enterprise-grade infrastructure and security posture. This established backing and explicit security certification provide a slight advantage.
Innovation
CardioLogs ECG Analysis PlatformCardioLogs is recognized for pioneering medical-grade AI and deep neural networks for ECG analysis, including compatibility with smartwatches, effectively 'reinventing cardiology diagnostics.' Its focus on diverse ECG data sources and continuous innovation in AI-powered cardiac biomarkers demonstrates a broader and more foundational innovative approach in its field.
Support & Docs
CardioLogs ECG Analysis PlatformCardioLogs provides clear channels for technical support through its platform's 'Help' menu and offers various documentation like brochures and white papers. As part of Philips, it benefits from an extensive and established support network. In contrast, cmAngio has less publicly available information regarding its support structure or documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CardioLogs ECG Analysis Platform | cmAngio® |
|---|---|---|
| Tool Name | CardioLogs ECG Analysis Platform | cmAngiou00ae |
| Company | Cardiologs Technologies (now part of Philips) | CureMetrix |
| Description | The Cardiologs ECG Analysis Platform, now a Philips solution, uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, aiding physicians in arrhythmia detection and diagnosis. | cmAngiou00ae by CureMetrix is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. |
| Key Features | AI-Powered ECG Analysis (Deep Neural Networks), Cloud-Based Platform, Multi-Device Compatibility (Holter, smartwatches, ECG patches), Automated Arrhythmia Detection (e.g., AFib, VT), Customizable Reports, Integration with EHR Systems, Real-Time Monitoring/Analysis, Data Encryption & Secure Hosting (ISO/IEC 27001 certified AWS servers) | AI-based detection of Breast Arterial Calcifications (BAC), Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams, Provides visualization of BAC location on a scorecard, Enables BAC identification and reporting without additional radiation or procedures, Compatible with any DICOM-compliant viewer, Adjustable operating point to meet clinical goals, Quick and easy installation (less than an hour), Cybersecure and HIPAA-compliant |
Videos
Demos, reviews, and walkthroughs featuring CardioLogs ECG Analysis Platform and cmAngio®.